Standout Papers

Comparison of the efficacy and safety o... 1995 2026 2005 2015 3.2k
  1. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials (2013)
    Christian T. Ruff, Robert P. Giugliano et al. The Lancet
  2. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death (2015)
    Silvia G. Priori, C. Blomström‐Lundqvist et al. European Heart Journal
  3. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II (2000)
    Bertram Pitt, Philip A. Poole‐Wilson et al. The Lancet
  4. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death (2015)
    Silvia G. Priori, C. Blomström‐Lundqvist et al. EP Europace
  5. A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction (1995)
    Lars Køber, Christian Torp‐Pedersen et al. New England Journal of Medicine
  6. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction (1996)
    Albert L. Waldo, A. John Camm et al. The Lancet
  7. Resting Heart Rate in Cardiovascular Disease (2007)
    Kim Fox, Jeffrey Borer et al. Journal of the American College of Cardiology
  8. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (2006)
    Douglas P. Zipes, A. John Camm et al. Circulation
  9. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation (2013)
    Hein Heidbüchel, Peter Verhamme et al. EP Europace
  10. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram (1991)
    Thomas Farrell, Yaver Bashir et al. Journal of the American College of Cardiology
  11. 2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation (2012)
    A. John Camm, Gregory Y.H. Lip et al. Revista Española de Cardiología (English Edition)
  12. Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias (2001)
    Maria Teresa La Rovere, Gian Domenico Pinna et al. Circulation
  13. Heart rate variability (1990)
    Marek Malík, A. John Camm Clinical Cardiology
  14. Relation of Helicobacter pylori infection and coronary heart disease. (1994)
    Michael A. Mendall, Patrick Goggin et al. Heart
  15. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors (1995)
    P Patel, M.A. Mendall et al. BMJ
  16. XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation (2015)
    A. John Camm, Pierre Amarenco et al. European Heart Journal
  17. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death (2015)
    Silvia G. Priori, Carina Blomström‐Lundqvist et al. Kardiologia Polska
  18. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update (2020)
    Michael Glikson, Rafael Wolff et al. EuroIntervention
  19. Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure (2021)
    Andreas Rillig, Christina Magnussen et al. Circulation
  20. The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation (2022)
    A. John Camm, Gerald V. Naccarelli et al. Journal of the American College of Cardiology
  21. Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials (2023)
    William F. McIntyre, Alexander P. Benz et al. Circulation
  22. Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal (2023)
    Gregory Y.H. Lip, Marco Proietti et al. EP Europace

Immediate Impact

3 by Nobel laureates 5 from Science/Nature 104 standout
Sub-graph 1 of 14

Citing Papers

Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
2025 Standout
Myocarditis
2022 Standout

Works of A. John Camm being referenced

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013 Standout

Author Peers

Author Last Decade Papers Cites
A. John Camm 40183 5189 3641 3861 893 46.2k
Harry J.G.M. Crijns 35250 3255 4113 3396 595 41.1k
Kurt Huber 21404 9514 4537 2576 835 32.3k
Hugh Calkins 48649 5908 3402 2004 731 53.2k
Christian Torp‐Pedersen 31274 6954 2968 3244 1.3k 50.3k
Gunnar Gislason 15214 5197 2898 1720 917 30.3k
Frans Van de Werf 30131 12126 4553 2542 746 39.2k
Jeffrey L. Anderson 18971 7827 1759 2831 516 34.3k
David A. Morrow 28608 12434 2586 3971 579 42.3k
Kent R. Bailey 32444 8396 2541 2532 580 43.0k
Gerd Hasenfuß 22843 4818 1762 9710 599 31.7k

All Works

Loading papers...

Rankless by CCL
2026